Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 44 Glioma 16 Melanoma 11 Central Nervous System Neoplasms 11 Astrocytoma 11 Brain Neoplasms 10 Oligodendroglioma 7 Gliosarcoma 5 Small Cell Lung Carcinoma 4 Recurrence 3 Lymphoma 3 Leiomyosarcoma 3 Sarcoma 2 Neoplasms, Neuroepithelial 2 Neoplasms 2 Neoplasm Metastasis 2 Ependymoma 2 Diffuse Intrinsic Pontine Glioma 2 Breast Neoplasms 2 Uveal Melanoma 1 Seizures 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Extensive Stage Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pituitary Neoplasms 1

Interventions

Temozolomide 1 Standard of Care 1 Medical Marijuana 1 Drug Therapy 1 Aspirin 1 Anticonvulsants 1 Airway Extubation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Seizures × Temozolomide × Clear all

NCT04450160 2020-06-29

AEO

MetVital, Inc.

Phase 2 Unknown

Glioblastoma, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡